Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-01

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this project was to investigate the short-term in situ anti-plaque effect of cymenol, using the Dentius Deep Plaque software

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva

NCT06437262

Healthy Saliva Biofilms

COMPLETED PHASE1

The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis

NCT02193165

Dental Plaque Gingivitis

COMPLETED PHASE3

Evaluating Commercial Anti-Plaque Products and Oral Rinse

NCT01014143

Dental Plaque

COMPLETED PHASE2

Clinical Research Study to Assess the Efficacy of Two Brushing Regimens

NCT06240481

Dental Plaque Gingivitis

RECRUITING PHASE3

Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.

NCT02194023

Dental Plaque Side Effects

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Dental Plaque

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Participants rinsed 10 ml of placebo mouthwash for a period of 60 seconds, three times a day with an interval of 7-9 hours in between, for 4 days (period 1)

Group Type PLACEBO_COMPARATOR

Placebo Mouthwash

Intervention Type DRUG

Application of mouthwashes

Cymenol (test)

Participants applied a 10 ml rinse of 0.1% cymenol mouthwash for a period of 60 seconds, three times a day with a 7-9 hour interval in between, for 4 days (period 1) and 4 days more (period 2)

Group Type EXPERIMENTAL

Cymenol mouthwash

Intervention Type DRUG

Application of mouthwashes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo Mouthwash

Application of mouthwashes

Intervention Type DRUG

Cymenol mouthwash

Application of mouthwashes

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Systemically healthy volunteers
* Age between 20-45 years
* Presence of minimum of 24 permanent teeth
* No evidence of gingivitis or periodontitis (CPITN= 0)
* No presence of untreated caries at the start of the study.